Determinants of recurrence after intended curative resection for colorectal cancer
- PMID: 25370351
- DOI: 10.3109/00365521.2014.926981
Determinants of recurrence after intended curative resection for colorectal cancer
Abstract
Despite intended curative resection, colorectal cancer will recur in ∼45% of the patients. Results of meta-analyses conclude that frequent follow-up does not lead to early detection of recurrence, but improves overall survival. The present literature shows that several factors play important roles in development of recurrence. It is well established that emergency surgery is a major determinant of recurrence. Moreover, anastomotic leakages, postoperative bacterial infections, and blood transfusions increase the recurrence rates although the exact mechanisms still remain obscure. From pathology studies it has been shown that tumors behave differently depending on their location and recur more often when micrometastases are present in lymph nodes and around vessels and nerves. K-ras mutations, microsatellite instability, and mismatch repair genes have also been shown to be important in relation with recurrences, and tumors appear to have different mutations depending on their location. Patients with stage II or III disease are often treated with adjuvant chemotherapy despite the fact that the treatments are far from efficient among all patients, who are at risk of recurrence. Studies are now being presented identifying subgroups, in which the therapy is inefficient. Unfortunately, only few of these facts are implemented in the present follow-up programs. Therefore, further research is urgently needed to verify which of the well-known parameters as well as new parameters that must be added to the current follow-up programs to identify patients at risk of recurrence.
Keywords: colorectal cancer; disease-free survival; follow-up program; recurrence; surgery.
Similar articles
-
Serum carcinoembryonic antigen levels in patients operated for colorectal carcinoma.Wien Klin Wochenschr. 2001;113 Suppl 3:32-8. Wien Klin Wochenschr. 2001. PMID: 15503618
-
Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.Ann Surg. 2007 Dec;246(6):1040-6. doi: 10.1097/SLA.0b013e318142d918. Ann Surg. 2007. PMID: 18043108
-
Association between recurrence of sporadic colorectal cancer, high level of microsatellite instability, and loss of heterozygosity at chromosome 18q.Dis Colon Rectum. 2004 Sep;47(9):1467-82. doi: 10.1007/s10350-004-0628-6. Epub 2004 Aug 12. Dis Colon Rectum. 2004. PMID: 15486743
-
Surgical approach in locally advanced colorectal cancer--combined, extended and compound surgery.Khirurgiia (Sofiia). 2013;(4):29-50. Khirurgiia (Sofiia). 2013. PMID: 24800318 Review. Bulgarian, English.
-
[Principles of oncologic drug therapy following surgery for bowel cancer].Duodecim. 2016;132(12):1155-9. Duodecim. 2016. PMID: 27483631 Review. Finnish.
Cited by
-
Mechanism of Preventing Recurrence of Stage II-III Colorectal Cancer Metastasis with Immuno-inflammatory and Hypoxic Microenvironment by a Four Ingredients Chinese Herbal Formula: A Bioinformatics and Network Pharmacology Analysis.Curr Pharm Des. 2024;30(25):2007-2026. doi: 10.2174/0113816128294401240523092259. Curr Pharm Des. 2024. PMID: 38867534
-
Mechanisms of Actinidia chinensis Planch in treating colon cancer based on the integration of network pharmacology, molecular docking, and experimental verification.Hereditas. 2023 Dec 15;160(1):39. doi: 10.1186/s41065-023-00303-x. Hereditas. 2023. PMID: 38102686 Free PMC article.
-
Blocking the Increase of Intracellular Deuterium Concentration Prevents the Expression of Cancer-Related Genes, Tumor Development, and Tumor Recurrence in Cancer Patients.Cancer Control. 2022 Jan-Dec;29:10732748211068963. doi: 10.1177/10732748211068963. Cancer Control. 2022. PMID: 35043700 Free PMC article.
-
IBSP, a potential recurrence biomarker, promotes the progression of colorectal cancer via Fyn/β-catenin signaling pathway.Cancer Med. 2021 Jun;10(12):4030-4045. doi: 10.1002/cam4.3959. Epub 2021 May 13. Cancer Med. 2021. PMID: 33987980 Free PMC article.
-
Tissue micro-RNAs associated with colorectal cancer prognosis: a systematic review.Mol Biol Rep. 2021 Feb;48(2):1853-1867. doi: 10.1007/s11033-020-06075-1. Epub 2021 Feb 17. Mol Biol Rep. 2021. PMID: 33598796
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous